Table: Daito - 9-MTH group results

Daito Pharmaceutical

14/04/2025 07:32

Apr 14 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Feb 28, 2025        Feb 29, 2024     May 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             36.61               34.66            49.00    
                 (+5.6 pct)          (+0.3 pct)       (+4.5 pct)  
  Operating          1.87                3.11             2.45    
                 (-39.8 pct)         (-24.4 pct)      (-37.1 pct) 
  Recurring          2.03                3.12             2.60    
                 (-34.9 pct)         (-23.4 pct)      (-33.7 pct) 
  Net                1.22                2.34             1.50    
                 (-48.0 pct)         (-12.1 pct)      (-54.5 pct) 
  EPS             79.73 yen          148.35 yen        98.24 yen  
  Ann Div                             60.00 yen        70.00 yen  
  -Q2 div         35.00 yen           30.00 yen                   
  -Q4 div                             30.00 yen        35.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T